|
C14ORF169 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.490300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.119570E-01 |
| Normal-vs-Stage2 |
8.815800E-01 |
| Normal-vs-Stage3 |
2.544300E-02 |
| Normal-vs-Stage4 |
8.403200E-03 |
| Stage1-vs-Stage2 |
9.065700E-02 |
| Stage1-vs-Stage3 |
1.565420E-01 |
| Stage1-vs-Stage4 |
5.151600E-02 |
| Stage2-vs-Stage3 |
2.369800E-02 |
| Stage2-vs-Stage4 |
8.937400E-03 |
| Stage3-vs-Stage4 |
4.853600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.495600E-02 |
| Normal-vs-AfricanAmerican |
1.023410E-01 |
| Normal-vs-Asian |
5.948200E-01 |
| Caucasian-vs-AfricanAmerican |
5.553000E-01 |
| Caucasian-vs-Asian |
2.458200E-01 |
| AfricanAmerican-vs-Asian |
2.294000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.576200E-02 |
| Normal-vs-Female |
1.032610E-01 |
| Male-vs-Female |
3.500400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.159700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.914580E-01 |
| Normal-vs-Age(61-80Yrs) |
2.166000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.624550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.086200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.026600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.649200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.177010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.487000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.870000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.397800E-02 |
| Classical-VS-Follicular |
3.814100E-02 |
| Classical-VS-Other |
1.030640E-01 |
| Classical-VS-Normal |
2.964000E-01 |
| Tall-VS-Follicular |
4.657400E-01 |
| Tall-VS-Other |
6.949200E-01 |
| Tall-VS-Normal |
1.317730E-02 |
| Follicular-VS-Other |
4.270600E-01 |
| Follicular-VS-Normal |
3.052000E-02 |
| Other-VS-Normal |
5.438500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.306850E-01 |
| Normal-vs-N1 |
4.660800E-03 |
| N0-vs-N1 |
6.322100E-02 |
|
|
